Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.

Punzalan CS, Barry C, Zacharias I, Rodrigues J, Mehta S, Bozorgzadeh A, Barnard GF.

Clin Transplant. 2015 Dec;29(12):1105-11. doi: 10.1111/ctr.12634. Epub 2015 Oct 9.

PMID:
26358816
2.

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.

Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1.

3.

Increased risk for CRC in diabetic patients with the nonrisk allele of SNPs at 8q24.

Ishimaru S, Mimori K, Yamamoto K, Inoue H, Imoto S, Kawano S, Yamaguchi R, Sato T, Toh H, Iinuma H, Maeda T, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Sugihara K, Hase K, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Barnard GF, Miyano S, Mori M.

Ann Surg Oncol. 2012 Sep;19(9):2853-8. doi: 10.1245/s10434-012-2278-6. Epub 2012 Mar 21.

PMID:
22434246
4.

CD13 is a therapeutic target in human liver cancer stem cells.

Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M.

J Clin Invest. 2010 Sep;120(9):3326-39. doi: 10.1172/JCI42550. Epub 2010 Aug 9.

5.

Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.

Mimori K, Ishii H, Inoue H, Barnard GF, Mori M.

J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S205-9. doi: 10.1111/j.1440-1746.2008.05439.x.

PMID:
19120899
6.

A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease.

Utsunomiya T, Okamoto M, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Aishima S, Yoshikawa Y, Hanai T, Inoue H, Barnard GF, Mori M.

World J Gastroenterol. 2007 Jan 21;13(3):383-90.

7.

Endoscopic diagnosis and removal of Ascaris lumbricoides during colonoscopy for polyp surveillance (with video).

Eckardt AJ, Barnard GF.

Gastrointest Endosc. 2006 Apr;63(4):708-9, discussion 709. No abstract available.

PMID:
16564883
8.

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M.

Cancer Res. 2006 Mar 1;66(5):2683-90.

9.

The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers.

Mimori K, Nagahara H, Sudo T, Ishii H, Yamashita K, Barnard GF, Mori M.

J Surg Oncol. 2006 Jan 1;93(1):44-6.

PMID:
16353180
10.

Characterization of a side population of cancer cells from human gastrointestinal system.

Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M.

Stem Cells. 2006 Mar;24(3):506-13. Epub 2005 Oct 20.

11.

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.

Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6800-6.

12.

Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells.

Mimori K, Nagahara H, Barnard GF, Mori M.

Pancreas. 2005 Oct;31(3):299. No abstract available.

PMID:
16163070
13.

Identification of molecular markers for metastasis-related genes in primary breast cancer cells.

Mimori K, Kataoka A, Yoshinaga K, Ohta M, Sagara Y, Yoshikawa Y, Ohno S, Barnard GF, Mori M.

Clin Exp Metastasis. 2005;22(1):59-67.

PMID:
16132579
14.

Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.

Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.

Oncol Rep. 2005 Sep;14(3):707-12.

PMID:
16077979
15.
16.

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.

Nagahara H, Mimori K, Ohta M, Utsunomiya T, Inoue H, Barnard GF, Ohira M, Hirakawa K, Mori M.

Clin Cancer Res. 2005 Feb 15;11(4):1368-71.

17.

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.

Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M.

Clin Cancer Res. 2004 Dec 15;10(24):8243-9.

18.

A gene-expression signature can quantify the degree of hepatic fibrosis in the rat.

Utsunomiya T, Okamoto M, Hashimoto M, Yoshinaga K, Shiraishi T, Tanaka F, Mimori K, Inoue H, Watanabe G, Barnard GF, Mori M.

J Hepatol. 2004 Sep;41(3):399-406.

PMID:
15336442
19.

CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue.

Zivny J, Banner BF, Agrawal S, Pihan G, Barnard GF.

Dig Dis Sci. 2004 Apr;49(4):551-5. Review. No abstract available.

PMID:
15185856
20.

Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.

Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard GF.

Jpn J Cancer Res. 2002 Jul;93(7):789-97.

PMID:
12149145
21.

Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.

Shibuta J, Eto T, Kataoka A, Inoue H, Ueo H, Suzuki T, Barnard GF, Mori M.

Am J Gastroenterol. 2001 Dec;96(12):3419-24.

PMID:
11774959
22.

Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.

Kataoka A, Sadanaga N, Mimori K, Ueo H, Barnard GF, Sugimachi K, Auclair D, Chen LB, Mori M.

Clin Cancer Res. 2001 Sep;7(9):2815-20.

23.

Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer.

Matsuyama A, Inoue H, Shibuta K, Tanaka Y, Barnard GF, Sugimachi K, Mori M.

Cancer Res. 2001 Aug 1;61(15):5714-7.

24.

Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma.

Etoh T, Ueo H, Inoue H, Sato K, Utsunomiya T, Barnard GF, Kitano S, Mori M.

Ann Surg Oncol. 2001 Jun;8(5):407-12.

PMID:
11407514
25.

Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2.

Mitra P, De A, Ethier MF, Mimori K, Kodys K, Shibuta K, Mori M, Madison JM, Miller-Graziano C, Barnard GF.

Cell Signal. 2001 May;13(5):311-9.

PMID:
11369512
26.

Heparanase expression in clinical digestive malignancies.

Inoue H, Mimori K, Utsunomiya T, Sadanaga N, Barnard GF, Ueo H, Mori M.

Oncol Rep. 2001 May-Jun;8(3):539-42.

PMID:
11295076
27.

Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.

Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M.

Cancer Res. 2001 Mar 1;61(5):2145-53.

28.

Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.

Katsuta T, Lim C, Shimoda K, Shibuta K, Mitra P, Banner BF, Mori M, Barnard GF.

Am J Gastroenterol. 2000 Nov;95(11):3157-64.

PMID:
11095335
29.

The Porphyrias.

Bonkovsky HL, Barnard GF.

Curr Treat Options Gastroenterol. 2000 Dec;3(6):487-500.

PMID:
11096610
30.

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.

Mori M, Mimori K, Sadanaga N, Inoue H, Tanaka Y, Mafune K, Ueo H, Barnard GF.

Int J Cancer. 2000 Nov 15;88(4):575-8.

31.

Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration.

Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M.

Clin Cancer Res. 2000 Sep;6(9):3545-51.

32.

Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness.

Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S, Mori M.

Gut. 2000 Jul;47(1):50-6.

33.

Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.

Inoue H, Mimori K, Shiraishi T, Kataoka A, Sadanaga N, Ueo H, Barnard GF, Mori M.

Oncol Rep. 2000 Jul-Aug;7(4):871-4.

PMID:
10854560
34.

RT-PCR detection of breast cancer cells in sentinel lymph modes.

Kataoka A, Mori M, Sadanaga N, Ueo H, Tsuji K, Rai Y, Barnard GF, Sugimachi K.

Int J Oncol. 2000 Jun;16(6):1147-52.

PMID:
10811988
35.

L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.

Shibuta K, Inoue H, Sato K, Matsuyama A, Ueo H, Tanaka Y, Mafune K, Barnard GF, Mori M.

Jpn J Cancer Res. 2000 Feb;91(2):199-203.

PMID:
10761707
36.

alpha6 integrin expression in esophageal carcinoma.

Tanaka Y, Mimori K, Shiraishi T, Ohkura Y, Takubo K, Mafune K, Barnard GF, Mori M.

Int J Oncol. 2000 Apr;16(4):725-9.

PMID:
10717240
37.

IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.

Mathai J, Shimoda K, Banner BF, Mori M, Bonkovsky HL, Barnard GF.

J Interferon Cytokine Res. 1999 Sep;19(9):1011-8.

PMID:
10505743
39.

CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver.

Mitra P, Shibuta K, Mathai J, Shimoda K, Banner BF, Mori M, Barnard GF.

Int J Oncol. 1999 May;14(5):917-25.

PMID:
10200342
40.
41.

Lack of DMBT1 expression in oesophageal, gastric and colon cancers.

Mori M, Shiraishi T, Tanaka S, Yamagata M, Mafune K, Tanaka Y, Ueo H, Barnard GF, Sugimachi K.

Br J Cancer. 1999 Jan;79(2):211-3.

42.

Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.

Shimoda K, Begum NA, Shibuta K, Mori M, Bonkovsky HL, Banner BF, Barnard GF.

Hepatology. 1998 Jul;28(1):108-15.

PMID:
9657103
43.

Motility related protein 1 (MRP1/CD9) expression in colon cancer.

Mori M, Mimori K, Shiraishi T, Haraguchi M, Ueo H, Barnard GF, Akiyoshi T.

Clin Cancer Res. 1998 Jun;4(6):1507-10.

44.

Glyceraldehyde-3-phosphate dehydrogenase mRNA expression in hepatocellular carcinoma.

Yamagata M, Mori M, Begum NA, Shibuta K, Shimoda K, Barnard GF.

Int J Oncol. 1998 Mar;12(3):677-83.

PMID:
9472111
45.

Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.

Bonkovsky HL, Barnard GF.

Semin Liver Dis. 1998;18(1):57-65. Review.

PMID:
9516679
46.
47.

Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and digestive tract cancer.

Shibuta K, Begum NA, Mori M, Shimoda K, Akiyoshi T, Barnard GF.

Int J Cancer. 1997 Nov 27;73(5):656-62.

48.

Quantitation of liver RNA.

Barnard GF, Mori M.

Hepatology. 1997 Sep;26(3):803. No abstract available.

PMID:
9303519
49.

Massive volume paracentesis (up to 41 liters) for the outpatient management of ascites.

Smith GS, Barnard GF.

J Clin Gastroenterol. 1997 Jul;25(1):402-3. No abstract available.

PMID:
9412937
50.

Rectal Dieulafoy's or angiodysplasia?

Kalman DR, Banner BF, Barnard GF.

Gastrointest Endosc. 1997 Jul;46(1):91-2. No abstract available.

PMID:
9260719

Supplemental Content

Loading ...
Support Center